The experiences of patients with pulmonary. arterial hypertension receiving continuous intravenous infusion of epoprostenol (Flolan) and their support persons

被引:11
|
作者
Hall, Heather [1 ]
Cote, Joanne [2 ]
McBean, Althea [2 ]
Purden, Margaret [1 ]
机构
[1] McGill Univ, Jewish Gen Hosp, Sch Nursing, Ctr Nursing Res, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Jewish Gen Hosp, Div Cardiol, Montreal, PQ H3T 1E2, Canada
来源
HEART & LUNG | 2012年 / 41卷 / 01期
关键词
Epoprostenol; Pulmonary arterial hypertension; Qualitative; Resilience; Support persons; Technology; QUALITY-OF-LIFE; RESILIENCE; THERAPY; HOME; PROSTACYCLIN;
D O I
10.1016/j.hrtlng.2011.05.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: Little is known about the day-to-day experiences of patients and their support persons during the course of epoprostenol treatment for pulmonary arterial hypertension (PAH). The study objective was to describe the experiences of patients and their support persons adjusting to PAH and continuous intravenous epoprostenol. METHODS: A qualitative descriptive design with semistructured interviews was conducted jointly with the patient and his/her support person. Seven patients and their support persons (spouse, child, friend) were included. RESULTS: Patients demonstrated personal growth and resilience as they adapted to PAH. Four patient themes emerged: initial shock, figuring it out, giving life, and ongoing struggles. Themes specific to the support person included "their life is in my hands," pressure to perform, and continuation of my role. CONCLUSION: Nurses may assist these patients and support persons by teaching technical skills, problem-solving and troubleshooting strategies, mobilizing social support, and providing opportunities to reflect on lifestyle changes and long-term adjustment to PAH. Cite this article: Hall, H., Cote, J., McBean, A., & Purden, M. (2012, JANUARY/FEBRUARY). The experiences of patients with pulmonary arterial hypertension receiving continuous intravenous infusion of epoprostenol (Flolan) and their support persons. Heart & Lung, 41(1), 35-43. doi:10.1016/j.hrtlng.2011.05.007.
引用
收藏
页码:35 / 43
页数:9
相关论文
共 50 条
  • [21] Intravenous Epoprostenol for Management of Pulmonary Arterial Hypertension during Pregnancy
    Timofeev, Julia
    Ruiz, George
    Fries, Melissa
    Driggers, Rita W.
    AJP REPORTS, 2013, 3 (02): : 71 - 74
  • [22] Intravenous epoprostenol therapy in the treatment of pulmonary arterial hypertension in Singapore
    Choo, Jack
    Yap, Jonathan
    Ismail, Aidila
    Hon, Jin Shing
    Ruan, Wen
    Low, Andrea
    Lim, Soo Teik
    Tan, Ju Le
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2024, 53 (10) : 627 - 631
  • [23] Efficacy and limitations of continuous intravenous Epoprostenol therapy for idiopathic pulmonary arterial hypertension in Japanese children
    Nakayama, Tomotaka
    Shimada, Hiromitsu
    Takatsuki, Shinichi
    Hoshida, Hiroshi
    Ishikita, Takashi
    Matsuura, Hiroyuki
    Saji, Tsutomu
    CIRCULATION JOURNAL, 2007, 71 (11) : 1785 - 1790
  • [24] Comparative analysis of Micrococcus luteus isolates from blood cultures of patients with pulmonary hypertension receiving epoprostenol continuous infusion
    Hirata, Yoshinori
    Sata, Makoto
    Makiuchi, Yuko
    Morikane, Keita
    Wada, Akihito
    Okabe, Nobuhiko
    Tomoike, Hitonobu
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2009, 15 (06) : 424 - 425
  • [25] Low Incidence of Catheter-Related Complications in Patients With Advanced Pulmonary Arterial Hypertension Undergoing Continuous Epoprostenol Infusion
    Nagai, Toshiyuki
    Kohsaka, Shun
    Anzai, Toshihisa
    Yoshikawa, Tsutomu
    Fukuda, Keiichi
    Sato, Toru
    CHEST, 2012, 141 (01) : 272 - 273
  • [26] Gastric Epithelial Neoplasms in Patients with Pulmonary Arterial Hypertension Receiving Continuous Intravenous Prostacyclin Therapy
    Mannami, Tomohiko
    Tanaka, Takehiro
    Shimokawahara, Hiroto
    Horikawa, Kyosuke
    Shinno, Yoko
    Umekawa, Tsuyoshi
    Sakaki, Tsukasa
    Fukumoto, Yasushi
    Shimizu, Shin'ichi
    Nozaki, Isao
    Ogawa, Aiko
    Matsubara, Hiromi
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (03)
  • [27] Long-term sildenafil added to intravenous epoprostenol in patients with pulmonary arterial hypertension
    Simonneau, Gerald
    Rubin, Lewis J.
    Galie, Nazzareno
    Barst, Robyn J.
    Fleming, Thomas R.
    Frost, Adaani
    Engel, Peter
    Kramer, Mordechai R.
    Serdarevic-Pehar, Marjana
    Layton, Gary R.
    Sitbon, Olivier
    Badesch, David B.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (07): : 689 - 697
  • [28] Primary pulmonary hypertension: Improved long-term effects and survival with continuous intravenous epoprostenol infusion
    Shapiro, SM
    Oudiz, RJ
    Cao, TS
    Romano, MA
    Beckmann, XJ
    Georgiou, D
    Mandayam, S
    Ginzton, LE
    Brundage, BH
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (02) : 343 - 349
  • [29] Acute hemodynamic effects of intravenous adenosine in patients with associated pulmonary arterial hypertension: Comparison with intravenous epoprostenol
    Rossi, Rosario
    Coppi, Francesca
    Sgura, Fabio
    Monopoli, Daniel
    Boriani, Giuseppe
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2018, 49 : 147 - 151
  • [30] Epoprostenol infusion therapy changes angiographic findings of pulmonary arteries in patients with idiopathic pulmonary arterial hypertension
    Sakuma, Masahito
    Demachi, Jun
    Nawata, Jun
    Suzuki, Jun
    Takahashi, Tohru
    Matsubara, Hiromi
    Akagi, Satoshi
    Shirato, Kunio
    CIRCULATION JOURNAL, 2008, 72 (07) : 1147 - 1151